302 related articles for article (PubMed ID: 17096009)
1. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
Dandona P; Dhindsa S; Ghanim H; Chaudhuri A
J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
Strawn WB
Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
[TBL] [Abstract][Full Text] [Related]
3. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
4. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
5. Inflammation may be a bridge connecting hypertension and atherosclerosis.
Li JJ; Chen JL
Med Hypotheses; 2005; 64(5):925-9. PubMed ID: 15780486
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II and vascular inflammation.
Cheng ZJ; Vapaatalo H; Mervaala E
Med Sci Monit; 2005 Jun; 11(6):RA194-205. PubMed ID: 15917731
[TBL] [Abstract][Full Text] [Related]
7. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
[TBL] [Abstract][Full Text] [Related]
8. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
9. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
10. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
Schulman IH; Zhou MS; Raij L
J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
[TBL] [Abstract][Full Text] [Related]
11. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
[TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system in atherosclerosis].
Fukuda D; Sata M
Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II as a pro-inflammatory mediator.
Phillips MI; Kagiyama S
Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture.
Kim MP; Zhou M; Wahl LM
J Leukoc Biol; 2005 Jul; 78(1):195-201. PubMed ID: 15817699
[TBL] [Abstract][Full Text] [Related]
16. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
[TBL] [Abstract][Full Text] [Related]
17. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
Dagenais NJ; Jamali F
Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395
[TBL] [Abstract][Full Text] [Related]
19. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-II behaves as an endogenous pro-inflammatory molecule.
Das UN
J Assoc Physicians India; 2005 May; 53():472-6. PubMed ID: 16124358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]